TNF and rheumatoid arthritis: AOPP in plasma of patients with RA decreased by 17% 6 months after start of anti-TNF-α therapy without reaching statistical significance (from 1.60 to 1.33 μmol/g, Figure 1(b), F = 2.2, p = 0.41).